MICHAEL TAYLOR to Pyridines
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Pyridines.
Connection Strength
0.066
-
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy. Nat Commun. 2019 12 20; 10(1):5829.
Score: 0.035
-
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma. Cancer Res. 2018 08 15; 78(16):4745-4759.
Score: 0.031